CCSD Code T1410: Needle Biopsy of Pleura – UK Billing Guide

Key Takeaways

CCSD code T1410 covers needle biopsy of the pleura for diagnostic tissue sampling in UK private practice.

Pre-authorisation is required by most major UK insurers before performing this procedure – confirm with each insurer in advance.

ICD-10 diagnosis codes such as J91.8, J94.8, or C38.4 commonly pair with T1410, but must reflect the documented clinical indication.

Imaging guidance for pleural biopsy may be billed under a separate CCSD code; insurer rules vary significantly.

Healthcode is the standard electronic submission platform for T1410 claims across UK private insurers.

A missed pre-authorisation on a pleural biopsy claim can result in full claim rejection – even when the procedure itself was clinically appropriate and correctly coded. For UK private practice clinicians and billing administrators, CCSD code T1410 needle biopsy pleura sits at the intersection of thoracic surgery, interventional radiology, and private insurer compliance, making accurate coding and documentation critical to successful reimbursement.

This guide covers everything billing staff and clinicians need to know about T1410 in the UK private healthcare setting: the procedure’s clinical scope, documentation requirements aligned with GMC and CQC standards, insurer-specific pre-authorisation considerations, related CCSD codes commonly billed alongside T1410, and how to submit claims correctly through Healthcode using practice management software. Each section is designed to help practices reduce claim rejections and maintain clean audit trails for this thoracic procedure.

CCSD Code T1410 Needle Biopsy of Pleura: Procedure Definition and Scope

The Clinical Coding and Schedule Development (CCSD) Group maintains the procedural coding schedule used by UK private healthcare insurers. Within this schedule, T1410 is defined as needle biopsy of the pleura – a minimally invasive diagnostic procedure in which a needle is passed through the chest wall to obtain a tissue sample from the pleural membrane or adjacent structures. Clinicians should verify the current CCSD schedule version at ccsd.org.uk to confirm this code description remains unchanged in the latest release.

The procedure is typically performed to investigate pleural effusion, pleural thickening, suspected mesothelioma, or other pleural pathology where cytology alone has not yielded a definitive diagnosis. Histopathological analysis of the biopsy specimen distinguishes it from a simple thoracocentesis, which is a fluid aspiration procedure coded separately under the CCSD schedule.

CCSD Code T1410 Needle Biopsy Pleura: Clinical Indications

T1410 applies when tissue sampling is the primary objective of the procedure. Common clinical indications include:

• Exudative pleural effusion of unknown aetiology requiring histopathological diagnosis
• Suspected pleural mesothelioma (ICD-10: C45.0) in patients with occupational asbestos exposure history
• Pleural thickening (ICD-10: J94.8) identified on imaging that has not resolved with conservative management
• Metastatic pleural disease (ICD-10: C38.4) requiring tissue confirmation before oncological treatment planning
• Chronic pleural inflammation or undiagnosed pleural pathology after non-diagnostic cytology

The distinction between a diagnostic biopsy and a therapeutic drainage procedure matters for CCSD billing purposes. If a thoracocentesis (fluid drainage) is performed at the same session, it should be coded separately under the applicable CCSD thoracic drainage code rather than bundled with T1410. Insurer unbundling rules apply – verify against each insurer’s fee schedule before billing both codes on the same claim.

Ultrasound-Guided vs CT-Guided CCSD Code T1410 Needle Biopsy Pleura

Needle biopsy of the pleura is frequently performed under imaging guidance to improve accuracy and reduce the risk of pneumothorax. The most common modalities are ultrasound guidance and CT guidance. Under the CCSD schedule, T1410 covers the biopsy procedure itself – imaging guidance is typically coded separately using the relevant CCSD radiology guidance code.

Whether a separate imaging guidance code can be billed alongside T1410 depends on the insurer. Bupa, AXA Health, and Aviva each publish their own guidance on procedural add-on billing; some apply strict unbundling rules that may include imaging guidance within the primary procedure fee. According to the CCSD Technical Guide (updated October 2025), clinicians should review the schedule’s business rules section to determine which codes can be billed concurrently. When in doubt, obtain written pre-authorisation that explicitly covers both the biopsy and the imaging guidance before proceeding.

CCSD Code T1410 Needle Biopsy Pleura: Quick Reference Chart

The table below provides a quick-reference summary for CCSD code T1410 needle biopsy pleura, including the procedure description, typical clinical indications, and the ICD-10 diagnosis codes most commonly documented alongside this procedure. These diagnosis code pairings are examples only – the code recorded must always reflect the actual documented clinical indication for that patient.

ICD-10 diagnosis code pairings are indicative only. The British Thoracic Society (BTS) guidelines for pleural disease provide clinical criteria that help support the diagnostic indication for a needle biopsy. Documenting the clinical decision-making rationale – including why biopsy was chosen over repeat cytology – strengthens the medical necessity justification for insurer review and CQC inspection purposes.

CCSD Code T1410 Documentation Requirements for UK Private Practice

Thoracic biopsy procedures carry a higher documentation burden than routine outpatient consultations. Insurers auditing T1410 claims expect clinical records to clearly support both the medical necessity of the procedure and the accuracy of the CCSD code assigned. The General Medical Council’s Good Medical Practice standards require that clinical records are legible, contemporaneous, and sufficient to allow another clinician to understand the care provided.

For T1410 specifically, practices should ensure the patient record contains the following before submitting a claim through their digital clinical documentation system:

CCSD Code T1410 Needle Biopsy Pleura: Required Documentation Elements

• Clinical indication: A documented diagnosis or differential diagnosis explaining why pleural tissue sampling was required, supported by imaging reports or prior clinical notes
• Consent record: Written informed consent for an invasive biopsy procedure, including discussion of risks (pneumothorax, bleeding, infection) in accordance with the Montgomery ruling
• Procedure note: A contemporaneous operative note recording approach, guidance modality used, number of passes, specimen obtained, and immediate post-procedure status
• Histopathology request: Laboratory request form and chain-of-custody documentation confirming specimen was sent for analysis
• Post-procedure observation: A record of the patient’s post-procedure clinical status, including whether a chest X-ray was performed to exclude pneumothorax
• Diagnosis code justification: The ICD-10 code recorded must be supported by the documented clinical findings – never assigned prospectively or based on a working hypothesis alone

The Care Quality Commission (CQC) expects that clinical records across all regulated activities support safe and effective care. During an inspection, surveyors may review procedural notes for invasive diagnostic procedures. Practices that maintain thorough, contemporaneous records for T1410 procedures are better positioned to respond to both insurer queries and CQC audit requests. A structured understanding of CQC requirements helps clinical leads build documentation standards into their billing workflows from the outset.

GDPR and Data Handling for T1410 Patient Records

Pleural biopsy records contain special category health data under UK GDPR. The Information Commissioner’s Office (ICO) requires that this data is stored securely, accessed only by authorised personnel, and retained in line with applicable healthcare records retention schedules. Practices must ensure their clinical record systems comply with UK GDPR obligations when handling T1410 procedure notes, histopathology results, and insurer correspondence. A UK GDPR compliance review for clinical records handling is advisable for any practice performing invasive diagnostic procedures.

Pre-Authorisation Requirements for CCSD Code T1410 Needle Biopsy Pleura

Needle biopsy of the pleura is classified as an invasive diagnostic procedure, and the majority of UK private insurers require pre-authorisation before it proceeds. Submitting a T1410 claim without a valid pre-authorisation reference number is one of the most common causes of outright claim rejection – not a request for additional information, but a full denial that requires an appeals process to overturn.

Pre-authorisation requirements vary by insurer, policy type, and policy year. Confirming the current position directly with the insurer’s provider services team before booking the procedure is essential. The following guidance reflects general patterns observed across major UK private insurers, but should not be treated as definitive – check the current position with each insurer before booking.

Bupa Pre-Authorisation for CCSD Code T1410 Needle Biopsy Pleura

Bupa typically requires pre-authorisation for invasive diagnostic procedures including pleural biopsy. Clinicians can use the Bupa code search portal to verify the current pre-authorisation requirements associated with T1410 and confirm whether the procedure is included on the patient’s policy before proceeding. Pre-authorisation requests for Bupa are submitted through their provider portal, and should include the CCSD code, the supporting clinical indication, and any planned imaging guidance code if applicable.

AXA Health Pre-Authorisation for CCSD Code T1410

AXA Health operates a specialist procedure authorisation system. Clinicians can review applicable procedure codes and associated authorisation requirements through the AXA Health specialist forms portal. For T1410, the clinical rationale for biopsy over alternative diagnostic approaches should be included in the authorisation request. AXA Health may also request confirmation of the planned guidance modality (ultrasound or CT) and whether a separate guidance code will be billed.

Aviva, Vitality, and WPA: CCSD T1410 Pre-Authorisation

Aviva publishes its procedure guidelines and fee schedule for recognised providers online. The Aviva fee schedule provides CCSD-coded fee information alongside invoicing requirements. Vitality Health maintains a fee finder tool that allows clinicians to look up T1410 and confirm whether it requires pre-authorisation under the applicable policy type. WPA operates through its recognised provider network and requires authorisation for invasive procedures – check WPA’s medical fees guidance for current requirements.

Across all insurers, the pre-authorisation reference number should be recorded in the patient record and included on the Healthcode claim submission. Missing or expired authorisation numbers are a leading cause of delays in payment processing for UK private practice billing. Practices using an automated billing workflow can flag procedures that require pre-authorisation before the appointment is confirmed, reducing the risk of performing an unbilled procedure.

Streamline CCSD billing and Healthcode submissions

Pabau helps UK private practices manage CCSD code workflows, automate pre-authorisation tracking, and submit claims electronically via Healthcode – reducing rejections and administrative overhead.

Book a demo

Billing CCSD Code T1410 Needle Biopsy of Pleura Alongside Related Codes

T1410 rarely appears in isolation on a private practice invoice. Pleural biopsy procedures are commonly performed alongside or immediately following an outpatient consultation, and they frequently involve imaging guidance that may be billed separately. Understanding which codes can legitimately accompany T1410 – and which combinations trigger unbundling rules – is critical for billing accuracy and avoiding claim queries.

CCSD Code T1410 Needle Biopsy Pleura With Imaging Guidance

When ultrasound or CT guidance is used during a pleural biopsy, the imaging guidance element is coded separately from T1410. The CCSD schedule contains specific imaging guidance codes for real-time ultrasound and CT guidance used in interventional procedures. Before billing both T1410 and an imaging guidance code together, clinicians must verify that:

• The insurer’s fee schedule does not bundle imaging guidance into the T1410 procedure fee
• The pre-authorisation received covers both the biopsy and the guidance modality
• The procedure note documents that image guidance was used throughout (not just for initial planning) to justify the add-on code
• The radiologist or clinician performing the guidance is billing separately if the procedures are performed by different practitioners

Some insurers, including those following Healix’s fee schedule guidelines, apply strict unbundling rules to interventional radiology combinations. The Healix fee schedule includes explicit guidance on which procedural combinations are permitted. When operating under Cigna or Allianz Care policies, the same principle applies – each insurer’s unbundling position should be confirmed before billing.

Combining CCSD Code T1410 With Consultation Codes

When a pleural biopsy is performed on the same day as an initial or follow-up outpatient consultation, practices may bill the consultation code and T1410 on the same invoice provided both were genuinely distinct episodes of care. The consultation must not simply be the pre-procedural discussion immediately before the biopsy. If the consultation represents a substantive clinical assessment – reviewing imaging, discussing differential diagnoses, and obtaining consent – it can legitimately accompany T1410 on the same insurance claim submission.

Insurers may query same-day consultation and procedure billing. Documenting the consultation and the procedure note as separate records, with distinct timestamps and clinical content, supports the legitimacy of billing both codes. The Association of British Insurers (ABI) has published general guidance on avoiding dual-billing concerns in private practice – practices should familiarise themselves with this position to inform their billing policies.

ICD-10 Diagnosis Coding Alongside CCSD Code T1410 Needle Biopsy Pleura

UK private insurer claims systems require an ICD-10 diagnosis code to accompany each procedure code. For T1410, the diagnosis code must reflect the documented clinical indication for the biopsy at the time of procedure – not a retrospective diagnosis derived from the histopathology result. Commonly used ICD-10 codes include:

• J91.8 – Pleural effusion in other conditions classified elsewhere, when biopsy is performed to investigate the cause of the effusion
• J94.8 – Other specified pleural conditions, including pleural thickening of uncertain aetiology
• C38.4 – Malignant neoplasm of pleura, when tissue confirmation of known or highly suspected malignancy is the clinical objective
• C45.0 – Mesothelioma of pleura, documented in patients with asbestos exposure history and pleural abnormalities consistent with mesothelioma
• D38.4 – Neoplasm of uncertain behaviour of pleura, when the biopsy objective is to establish whether a lesion is benign or malignant

If the diagnosis at the time of procedure is genuinely uncertain, the NHS Classifications Browser and NHS Digital clinical coding guidance provide support for selecting the most appropriate code when the primary condition has not yet been confirmed. Coding conventions for unconfirmed diagnoses differ between ICD-10 and clinical practice; ensure the coding reflects the diagnostic intent documented in the clinical notes rather than the clinician’s working hypothesis.

Submitting CCSD Code T1410 Needle Biopsy Pleura via Healthcode

Healthcode is the standard electronic data interchange (EDI) platform used by UK private healthcare insurers to receive and process claims. The majority of recognised providers – including thoracic surgeons, respiratory physicians, and interventional radiologists billing for pleural procedures – submit claims through Healthcode rather than by paper invoice. For T1410, electronic submission via Healthcode reduces processing times and creates a clear digital audit trail for each claim.

CCSD Code T1410 Needle Biopsy Pleura: Healthcode Submission Steps

A correctly structured Healthcode submission for T1410 includes the following elements, all of which must be present before the claim is transmitted:

1. Patient and policy details: Full name, date of birth, insurer name, policy number, and membership number as they appear on the insurance certificate
2. Pre-authorisation reference: The authorisation number issued by the insurer for this specific procedure – not a general open-authorisation number unless the insurer has confirmed it covers T1410
3. CCSD procedure code: T1410, entered as the primary procedure code; any additional codes (imaging guidance, consultation) entered as secondary line items in the correct order
4. ICD-10 diagnosis code: The code matching the documented clinical indication – entered in the diagnosis field, not the procedure field
5. Procedure date and location: The date the biopsy was performed and the facility name as registered with the insurer
6. Fee amount: The fee charged, cross-referenced against the insurer’s current CCSD fee schedule to reduce the risk of fee queries

Practices using integrated claims management software that connects directly with Healthcode can automate much of this process – populating CCSD codes from clinical records, flagging missing authorisation numbers, and transmitting claims without manual re-entry. This reduces transcription errors and accelerates cash flow for procedures such as T1410 that carry a higher administrative overhead.

Common CCSD Code T1410 Needle Biopsy Pleura Rejection Reasons

Understanding the most frequent rejection triggers for T1410 helps billing administrators resolve queries faster and build preventive checks into the submission workflow. The most commonly encountered rejection reasons for pleural biopsy claims in UK private practice include:

• Missing or invalid pre-authorisation number: The claim references an authorisation that does not match the patient’s policy or has expired before the procedure date
• Diagnosis code mismatch: The ICD-10 code submitted does not align with the clinical narrative in the supporting notes, triggering a medical necessity query
• Unbundled imaging guidance rejected: The insurer’s fee schedule includes imaging guidance within the T1410 fee, and the separate guidance code is denied as a duplicate
• Same-day consultation query: The insurer requests evidence that the consultation and the procedure were genuinely separate clinical events, not a single pre-procedural discussion
• Incorrect provider details: The treating clinician’s Healthcode registration details do not match the insurer’s recognised provider records

Maintaining a practice-level billing checklist – reviewed and updated each time an insurer revises its fee schedule or authorisation rules – is the most effective way to reduce rejection rates over time. The administrative efficiency gains from a structured pre-submission checklist are measurable: fewer rejected claims mean less time spent on appeals and resubmissions, and faster receipt of payment for completed procedures.

Reviewed against current CCSD schedule guidance and major UK private insurer provider documentation.

Expert Picks

Need a complete overview of CCSD billing for UK private practice? Bupa CCSD Codes Guide covers procedure code structures, Bupa-specific billing rules, and how to navigate the CCSD schedule for common private practice procedures.

Concerned about CQC compliance for invasive procedure documentation? CQC Inspection Checklist outlines the documentation and clinical governance standards inspectors evaluate during regulated activity reviews.

Looking to automate Healthcode claims submission for your practice? Claims Management Software describes how Pabau supports electronic CCSD claim submission, pre-authorisation tracking, and insurer integration for UK private practices.

Want to understand private practice billing compliance requirements more broadly? Benefits of Private Practice provides context on the operational and financial considerations clinicians face when setting up or managing a UK private practice.

Conclusion

CCSD code T1410 needle biopsy pleura is a diagnostically significant thoracic procedure that requires careful attention across every stage of the billing workflow – from pre-authorisation through to Healthcode submission. The most common failure points are predictable: missing authorisation references, ICD-10 codes that cannot be matched to the documented clinical indication, and imaging guidance billed without confirming the insurer’s position on concurrent coding.

Practices that invest in structured documentation templates, pre-submission checklists, and integrated billing systems that connect CCSD codes directly to clinical records are significantly better positioned to achieve clean first-time claim acceptance. Each rejected T1410 claim represents not only delayed revenue but an administrative burden that compounds across a busy thoracic or respiratory practice.

Building consistent billing processes around this code – and reviewing them each time a major insurer updates its CCSD fee schedule – is the practical path to reliable reimbursement for pleural biopsy procedures in UK private healthcare.

Frequently Asked Questions